Drug recall · July 20, 2016
Daytrana recall
Why: Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3.
- Lots / codes
Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16
- Quantity
- 12285 boxes
- Company
- Noven Pharmaceuticals, Inc., Miami, FL
- Distribution
- Nationwide
- Initiated
- December 21, 2015 · Voluntary: Firm initiated
- Classified
- July 14, 2016
- Reported
- July 20, 2016
- Ended
- March 19, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Daytrana
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.